NOVEL THERAPEUTICS FOR FIBROLAMELLAR CARCINOMA

$718,486FY2019Department of the ArmyDOD

University Of Washington, Seattle WA

Investigators

View source on USAspending →

NOVEL THERAPEUTICS FOR FIBROLAMELLAR CARCINOMA · GrantIndex